UCL Women is for academic UCL staff (postdoc and above) in science, technology, engineering and mathematics (STEM). Any eligible staff are welcome to as many or as few events as they like.
Please see the What’s new page to keep up-to-date with our events. You can also follow us on twitter at @UCLWomen for all the latest information. Do also feel free to contact us at firstname.lastname@example.org; we look forward to meeting new colleagues and making UCL a better place for all of us.
Next event news
The sun is finally shining and summer is on its way. As term winds down for yet another year, why not find some time in your busy diary to meet some fascinating colleagues from different disciplines across UCL?
Join us on 14 June 2017 for an informal talk in our popular ‘Who am I – what am I doing?” series, from Sara Mole, a Professor at the MRC Laboratory for Molecular Cell Biology. The title of her talk is “UCL Women in Leadership Programme – my perspective”.
We’ll meet from 12.30 to 2 PM in the usual place: room 305 of the hospitable Department of Psychology: 26 Bedford Way, WC1H 0AP. Go to the seminar room on the 3rd floor. You can buy drinks and sandwiches at the Café next door to the seminar room, or from one of the many eateries in Torrington Place, or bring your own! Step-free access is available immediately to the right of the main entrance.
Sara Mole read Biochemistry at the University of Cambridge, undertook her PhD at Imperial College, and two postdoctoral positions, one continuing her thesis work at the Imperial Cancer Research Fund, the second back at Cambridge when she moved into the then emerging field of molecular genetics. She was appointed Lecturer at UCL in 1992 and has been here ever since. She is now a Professor.
At UCL, Sara has always worked primarily on Batten disease (aka Neuronal Ceroid Lipofuscinoses, NCL). In this time her team and colleagues have identified many of the genes now known to cause Batten disease. They continue to try to understand the function of these genes and the cellular consequences when they are not working properly. UCL has a particular focus on developing new treatments using approaches including gene therapy and drug repurposing for Batten disease. Unusually Sara’s lab is also exploiting yeast as a model organism to achieve these aims.
Sara founded the NCL Mutation database in 1998 and later launched the web site NCL resource as a gateway to enable those encountering Batten disease for the first time to have access to accurate information and expertise. Sara is senior editor on a text book on Batten disease, published by Oxford University Press. She is currently leading the BATCure project that brings together experts from 14 different institutions across Europe, including the Batten Disease Family Association as a full partner, half of which have never worked on Batten disease before. Their focus is on developing new treatments.
Sara introduced the idea of working under the Athena Charter to her department, the MRC Laboratory for Molecular Cell Biology in 2008, and has led on its implementation from their first Silver award in 2009, its renewal in 2012 and their Gold award in 2016, together with co-chair Professor Rob de Bruin. The LMCB is often held up as a beacon of good practice within UCL. Sara champions Equality and Diversity within the Faculty of Life Science through the Equality & Diversity Committee, and tweets using #simplygoodpractice. She also serves on or chairs Athena SWAN panels. Recently she has been much in demand to talk about Athena SWAN and the journey to Athena Gold. Sara also initiated a new monthly network in 2016 known as UCL Women in Leadership which brings together senior academic and professional support staff who have shared a leadership development programme of the same name.
7 March 2017 from 17:30
In celebration of International Women’s Day, Dr Emmanuelle Charpentier, a pioneer of CRISPR-Cas9 technology, will give the 2017 UCL Women’s Flagship Lecture. CRISPR went from obscure bacterial defence system to household name in a few short years thanks to its immense power to ‘edit’ the genome. In this seminar, we’ll hear the inside story of this fascinating journey as well as learn more about the woman behind it.
There’ll be a drinks reception in the Cloisters (Wilkins Building, main quad of UCL) from 5.30pm, followed by the lecture in Cruciform Lecture Theatre 1 at 7pm. The lecture will be enhanced afterwards by a Q&A session, moderated by Alok Jha, science correspondent for ITV News.
This event is free and open to all, but spaces are limited, so book early to avoid disappointment! You can register for a maximum of two tickets.
Biography – Emmanuelle Charpentier
Dr Charpentier, a French biologist, is currently director of the Max Planck Institute for Infection Biology in Berlin. Her work was instrumental in understanding the molecular basis of the bacterial CRISPR-Cas9 “immune system” and exploiting it as a tool for genome editing. In collaboration with Jennifer Doudna and her team, Charpentier’s group worked out how to make precisely targeted mutations via synthetic “guide RNA” molecules. The method is now widely used to edit the DNA sequences of plants, animals, and mammalian cells, which will have wide-reaching effects on biology, healthcare and technology in the future. Charpentier has won the Breakthrough Prize in Life Sciences, the Gruber Foundation International Prize in Genetics and the Leibniz Prize, Germany’s most important research prize. In 2015, Time Magazine named Charpentier one of the 100 most influential people in the world (together with Jennifer Doudna).